BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03690388-completion@plaintrial.com
DTSTAMP:20261027T152856Z
DTSTART;VALUE=DATE:20260731
SUMMARY:A Study of Cabozantinib Compared With Placebo in Subjects With Radi
 oiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After
  Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Thera
 py — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03690388
URL:https://plaintrial.com/trial/NCT03690388
END:VEVENT
END:VCALENDAR